Selecting the right first-line treatment for patients with HR+ advanced breast cancer – How to risk stratify in the absence of biological markers?

E-session 415000 / Sponsored / NO CME Add to My Agenda

Session held in collaboration with AstraZeneca

The live session starts in about 15 days

Access to the live session is open 10 minutes before the start of the session

Share on:
Save to my calendar:

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

Nov 2017
18:15-19:00 CET

The live session starts in about 15 days